ATE202782T1 - Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendung - Google Patents
Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendungInfo
- Publication number
- ATE202782T1 ATE202782T1 AT95120444T AT95120444T ATE202782T1 AT E202782 T1 ATE202782 T1 AT E202782T1 AT 95120444 T AT95120444 T AT 95120444T AT 95120444 T AT95120444 T AT 95120444T AT E202782 T1 ATE202782 T1 AT E202782T1
- Authority
- AT
- Austria
- Prior art keywords
- preparation
- optically active
- active benzothiepine
- benzothiepine derivatives
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
- C07F9/655372—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/67—Phosphorus compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32727594 | 1994-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE202782T1 true ATE202782T1 (de) | 2001-07-15 |
Family
ID=18197308
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95120444T ATE202782T1 (de) | 1994-12-28 | 1995-12-22 | Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendung |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6346521B1 (de) |
| EP (1) | EP0719782B1 (de) |
| KR (1) | KR960022542A (de) |
| CN (1) | CN1058718C (de) |
| AR (1) | AR002018A1 (de) |
| AT (1) | ATE202782T1 (de) |
| AU (1) | AU689004B2 (de) |
| BR (1) | BR9506098A (de) |
| CA (1) | CA2166152A1 (de) |
| DE (1) | DE69521595T2 (de) |
| DK (1) | DK0719782T3 (de) |
| ES (1) | ES2158034T3 (de) |
| FI (1) | FI956273A7 (de) |
| GR (1) | GR3036757T3 (de) |
| HU (1) | HUT74562A (de) |
| NO (1) | NO303641B1 (de) |
| NZ (1) | NZ280745A (de) |
| PT (1) | PT719782E (de) |
| RU (1) | RU2162083C2 (de) |
| TW (1) | TW403757B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998008517A2 (en) | 1996-08-26 | 1998-03-05 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol |
| US5910492A (en) * | 1995-06-05 | 1999-06-08 | Takeda Chemical Industries, Ltd. | Osteogenic promoting pharmaceutical composition |
| NZ308658A (en) * | 1995-06-05 | 1999-10-28 | Takeda Chemical Industries Ltd | Sustained release synergistic pharmaceutical composition comprising a non-peptide osteogenetic promoting substance and a biodegradable polymer |
| CN1080723C (zh) * | 1995-07-24 | 2002-03-13 | 武田药品工业株式会社 | 光学活性苯并硫杂庚英盐类的生产方法 |
| CA2267930A1 (en) * | 1996-10-09 | 1998-04-16 | Nobuyuki Takechi | A method for producing a microparticle |
| AU4165699A (en) * | 1998-06-15 | 2000-01-05 | Takeda Chemical Industries Ltd. | Composition for treating cartilage disease |
| EP1103552A4 (de) | 1998-08-07 | 2003-01-15 | Takeda Chemical Industries Ltd | Benzothiepin-derivate, verfahren zu ihrer herstellung und ihre verwendungen |
| AR020158A1 (es) * | 1998-08-12 | 2002-04-10 | Takeda Chemical Industries Ltd | Mejorador del factor de induccion para la diferenciacion celular |
| AU5998799A (en) * | 1998-09-30 | 2000-04-17 | Takeda Chemical Industries Ltd. | Bone repair materials/artificial bone compositions |
| EP1286984A2 (de) * | 2000-03-10 | 2003-03-05 | Pharmacia Corporation | Verfahren zur herstellung von tetrahydrobenzothiepinen |
| EP1416919A1 (de) * | 2001-07-17 | 2004-05-12 | Teva Pharmaceutical Industries Ltd. | Dosierformen für die unmittelbare gastrische freisetzung eines calcium-transport-stimulators in verbindung mit der verzögerten gastrischen freisetzung eines bis-phosphonats |
| US20050026871A1 (en) * | 2002-07-17 | 2005-02-03 | Moshe Flashner-Barak | Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative |
| JPWO2005002590A1 (ja) * | 2003-07-01 | 2006-08-10 | アステラス製薬株式会社 | 骨量増加誘導剤 |
| WO2009006226A1 (en) * | 2007-06-29 | 2009-01-08 | Kci Licensing Inc. | Activation of bone and cartilage formation |
| CN102325754B (zh) | 2009-01-19 | 2014-03-12 | 第一三共株式会社 | 含杂原子的环状化合物 |
| BRPI1013988A2 (pt) | 2009-04-06 | 2016-04-05 | Daiichi Sankyo Co Ltd | composto, composição farmacêutica , e, uso de um composto ou um sal farmacologicamente aceitável do mesmo |
| JPWO2011136264A1 (ja) | 2010-04-28 | 2013-07-22 | 第一三共株式会社 | [5,6]複素環化合物 |
| JP6484555B2 (ja) | 2013-08-29 | 2019-03-13 | 京都薬品工業株式会社 | 新規芳香族化合物およびその用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138535A3 (en) * | 1983-10-13 | 1987-01-28 | British Telecommunications Plc | Visual display logic simulation system |
| US5158943A (en) * | 1988-11-21 | 1992-10-27 | Takeda Chemical Industries, Ltd. | Sulfur-containing heterocyclic compounds |
| DK656789A (da) * | 1988-12-28 | 1990-06-29 | Takeda Chemical Industries Ltd | Benzoheterocykliske forbindelser |
| DK0460488T3 (da) * | 1990-05-30 | 2001-09-17 | Takeda Chemical Industries Ltd | Svovlholdige heterocykliske forbindelser |
| JP3165866B2 (ja) * | 1990-06-06 | 2001-05-14 | 武田薬品工業株式会社 | 含硫黄複素環化合物 |
-
1995
- 1995-12-20 TW TW084113629A patent/TW403757B/zh not_active IP Right Cessation
- 1995-12-21 NZ NZ280745A patent/NZ280745A/en unknown
- 1995-12-22 EP EP95120444A patent/EP0719782B1/de not_active Expired - Lifetime
- 1995-12-22 ES ES95120444T patent/ES2158034T3/es not_active Expired - Lifetime
- 1995-12-22 DK DK95120444T patent/DK0719782T3/da active
- 1995-12-22 PT PT95120444T patent/PT719782E/pt unknown
- 1995-12-22 AU AU40693/95A patent/AU689004B2/en not_active Ceased
- 1995-12-22 DE DE69521595T patent/DE69521595T2/de not_active Expired - Fee Related
- 1995-12-22 AT AT95120444T patent/ATE202782T1/de not_active IP Right Cessation
- 1995-12-27 FI FI956273A patent/FI956273A7/fi unknown
- 1995-12-27 CA CA002166152A patent/CA2166152A1/en not_active Abandoned
- 1995-12-27 HU HU9503802A patent/HUT74562A/hu unknown
- 1995-12-27 BR BR9506098A patent/BR9506098A/pt unknown
- 1995-12-27 RU RU95122478/04A patent/RU2162083C2/ru active
- 1995-12-27 NO NO955305A patent/NO303641B1/no not_active IP Right Cessation
- 1995-12-28 US US08/579,731 patent/US6346521B1/en not_active Expired - Fee Related
- 1995-12-28 KR KR1019950061545A patent/KR960022542A/ko not_active Ceased
- 1995-12-28 AR ARP950100805A patent/AR002018A1/es unknown
- 1995-12-28 CN CN95121715A patent/CN1058718C/zh not_active Expired - Fee Related
-
2000
- 2000-08-09 US US09/635,067 patent/US6632807B1/en not_active Expired - Fee Related
-
2001
- 2001-09-28 GR GR20010401614T patent/GR3036757T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69521595T2 (de) | 2002-05-23 |
| NO303641B1 (no) | 1998-08-10 |
| KR960022542A (ko) | 1996-07-18 |
| NZ280745A (en) | 1997-09-22 |
| FI956273L (fi) | 1996-06-29 |
| EP0719782A1 (de) | 1996-07-03 |
| EP0719782B1 (de) | 2001-07-04 |
| DK0719782T3 (da) | 2001-09-24 |
| PT719782E (pt) | 2001-10-31 |
| HU9503802D0 (en) | 1996-02-28 |
| RU2162083C2 (ru) | 2001-01-20 |
| DE69521595D1 (de) | 2001-08-09 |
| CN1131669A (zh) | 1996-09-25 |
| FI956273A7 (fi) | 1996-06-29 |
| AU4069395A (en) | 1996-07-04 |
| HUT74562A (en) | 1997-01-28 |
| FI956273A0 (fi) | 1995-12-27 |
| GR3036757T3 (en) | 2001-12-31 |
| AU689004B2 (en) | 1998-03-19 |
| AR002018A1 (es) | 1998-01-07 |
| CN1058718C (zh) | 2000-11-22 |
| CA2166152A1 (en) | 1996-06-29 |
| TW403757B (en) | 2000-09-01 |
| NO955305D0 (no) | 1995-12-27 |
| US6346521B1 (en) | 2002-02-12 |
| ES2158034T3 (es) | 2001-09-01 |
| US6632807B1 (en) | 2003-10-14 |
| BR9506098A (pt) | 1997-12-23 |
| NO955305L (no) | 1996-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE258549T1 (de) | Oxazolidindion-derivate, ihre herstellung und verwendung | |
| DE69529026D1 (de) | Trehalose, ihre Herstellung und ihre Verwendung | |
| DE69814431D1 (de) | 3,3-diarylpropylamine , ihre verwendung und herstellung | |
| DE69525676D1 (de) | Polyurethan-Zusammensetzungen, ihre Herstellung und Verwendung | |
| DE59905572D1 (de) | Substituierte 4-amino-2-aryl-pyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
| DE59703980D1 (de) | Reaktivfarbstoffe, ihre Herstellung und Verwendung | |
| DE69625857D1 (de) | Siliconderivate, ihre Herstellung und Verwendung | |
| DE69521595D1 (de) | Optisch-aktives Benzothiepin-Derivate, ihre Herstellung und Verwendung | |
| DE69027170D1 (de) | Uracilderivate, ihre Herstellung und ihre Verwendung | |
| DE69835433D1 (de) | Disulfid-vernetzte glycoprotein-hormone, ihre herstellung und verwendung | |
| DE59710272D1 (de) | Neue alpha-hydroxysäurederivate, ihre herstellung und verwendung | |
| DE59409541D1 (de) | Bicyclen-derivate, ihre herstellung und verwendung | |
| DE59208576D1 (de) | 3-Isoxazolylphenylverbindungen, ihre Herstellung und ihre Verwendung | |
| DE69511579D1 (de) | Biozide alkohole, ihre herstellung und ihre verwendung | |
| ATE212346T1 (de) | 3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung | |
| ATE188705T1 (de) | 13-substituierte milbemycinderivate, ihre herstellung und verwendung | |
| ATE268760T1 (de) | Neue carbonsäurederivate, ihre herstellung und verwendung | |
| DE59510397D1 (de) | Halogenierte Biphenyl-2,2'diyl-bis-diphenylphosphine, ihre Herstellung und ihre Verwendung | |
| DE69723463D1 (de) | Cyclische organoselenderivate, ihre herstellung und verwendung | |
| DE59608127D1 (de) | Reaktivfarbstoffe, ihre Herstellung und Verwendung | |
| DE59501950D1 (de) | Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung | |
| ATE198192T1 (de) | Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung | |
| FI971317A7 (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö | |
| DE59509557D1 (de) | Reaktivfarbstoffe, ihre Herstellung und Verwendung | |
| DE69735015D1 (de) | Neue Creatin-amidinohydrolase, ihre Herstellung und Verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |